Akero Therapeutics soars after Novo Nordisk set for $5.2B cash acquisition

Novo Nordisk said on Thursday it would acquire Akero Therapeutics for up to $5.2 billion in cash, marking a significant push into treatments for fatty liver disease as the Danish drugmaker seeks to br... ...